For several decades, the use of animal-derived and synthetic biomaterials in clinical models has not consistently translated into life-saving treatments for human diseases or ailments. Humabiologics offers an alternative by providing biomaterials that are more clinically and physiologically relevant. Our human-derived biomaterials bridge the gap between research and real-world application, enhancing the potential for successful translational therapies.

Humabiologics exclusively collaborates with FDA-registered and American Association of Tissue Banks (AATB) accredited organizations to source transplant-quality donor tissues. Unlike other manufacturers who may use biomaterials from inadequately screened donor tissues, we ensure the highest quality through rigorous eligibility criteria based on various medical, social, and health factors. This meticulous screening process guarantees the excellence of the donated tissue. To date, we are one of the only companies offering high-quality native human-derived biomaterials specifically for regenerative medicine applications.

No. Recombinant collagen, i.e. synthesized collagen, for example, is produced by human fibroblasts cells, cell lines, or organisms. These biomaterials do not come from native human tissues and are instead isolated from culture, in vitro. Humabiologics’ biomaterials are distinct in that they are extracted directly from transplant-quality human donor tissues, ensuring their native origin. Although recombinant collagen may have a structure similar to native human collagen, it is not identical. Literature indicates biological differences between native human and recombinant collagen, affecting their performance in certain applications. Moreover, producing recombinant collagen in large quantities while keeping it affordable remains challenging. Humabiologics overcomes these issues by providing native human-derived biomaterials that are more consistent and affordable for regenerative medicine applications.

We maintain an ample inventory of our products that are ready to ship. For U.S. orders received before 3 PM MST from Monday to Wednesday, we offer same-day shipping for next-day delivery. For international orders, we ship on the next available Monday to ensure weekday delivery, with most orders arriving within 2-3 days. One of our representatives will stay in regular communication with you, keeping you informed about your order’s timeline. The shipping method is carefully selected based on the storage conditions required for our products, ensuring they arrive in optimal condition.

Yes! We have developed scalable manufacturing capabilities to meet various demands. We supply gram quantities of many products, including human collagen, to our customers. If your organization needs a larger quantity, we are more than happy to accommodate your request. Please contact us at info@humabiologics.com to arrange a call with our scientific and production team members.

Yes. Our products are manufactured under certified ISO 13485 Quality Management System (QMS).

Several of our customers are planning to use one or multiple products in clinical trials as part of their therapeutic platforms. Due to confidentiality agreements, we cannot disclose further details about their specific therapeutic platforms or indications.

Our products are for research use only (RUO) and are not intended for human use, diagnosis, screening, household, food, or other uses. They can only be used in humans as part of FDA submission.

Humabiologics’ facility has been registered with the FDA as a human cell and tissue establishment since 2021. We operate in an FDA-inspected facility, ensuring compliance with the highest standards of quality and safety.